Clatterbridge Cancer Centre – Independent clinical advice on the options for an interim model for Haemato-Oncology services In July 2019 the Northern England Clinical Senate received a referral from the Clatterbridge Cancer Centre (CCC) requesting independent clinical advice to inform decision-making on the interim model for Haemato-oncology (H-O). This request included particular reference to escalation and access to critical care services in the interim options services until the completion of the new Royal Liverpool Hospital (RLH) build.
In order to provide robust independent clinical advice in response to the agree Terms of Reference the Northern England Clinical Senate formed a review panel of experts within the relevant expertise and experience. This panel met with a series of organisational leaders, clinical and nursing leads and other staff from across the relevant specialties from both the CCC and the RLH as part of a review visit on the 2nd October 2019.
The review day included a visit to the haematology inpatient and day case facilities in current Royal Liverpool Hospital, a site visit to the new build CCC-Liverpool site and a physical walk-through of proposed critical transfer route between the CCC-L and the RLH outlined within some of the options to considered. The resulting advice was provided by the Northern England Clinical Senate to CCC on the 18th October 2019 and it was considered by the CCC Trust Board on the 27th November 2019.